Dr Reddy's Launches Generic Ozempic Brands Amid Supply Disruption
1 report, 1 independent
Updated Oct 23
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Dr Reddy's Laboratories launched two new generic brands, Obeda Pro and Obeda Plus, for Ozempic on October 23, 2026. This launch follows a supply disruption of the original Obeda injectable, whose supplies were halted in July after Dr Reddy's discovered an impurity in the active ingredient. The new brands are manufactured by a different company than the original injectable.
Why it matters
The introduction of these generic versions addresses supply issues in India's fast-growing semaglutide market. Distributors suggest Dr Reddy's Laboratories may discontinue the original Obeda injectable to focus on the new products.
Who's involved
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.